Potential markers found for stomach cancer prognosis

Posted on 2008-07-16 20:00:00 in Cancer | Diagnostics | GI-Digestive |

Researchers in Rhode Island have discovered two potential biomarkers that may be used to predict outcomes for stomach cancer patients.

According to the study, published in this month's issue of Clinical Cancer Research, stomach cancer patients with low levels of proteins gastrokine 1 and 2 (GKN1 and GKN2) are more likely to experience poor outcomes after surgery.

The median survival rate in patients with suppressed levels of GKN1 and GKN2 was about two years compared to a survival of more than ten years for patients with normal levels of the stomach proteins.

Lead author Dr Steven Moss, a gastroenterologist with Rhode Island Hospital, explained: "Unfortunately, stomach cancer is difficult to cure unless it's discovered early, but because the early stage of the disease has very few symptoms, the cancer is usually advanced by the time it's diagnosed.

"That's what makes our findings so significant, because if the potential markers identified in our study can help predict a patient's prognosis, we can decide right away which course of action to take and hopefully help patients live longer and more comfortably."

The National Cancer Institute states that approximately 760,000 new cases of stomach cancer are diagnosed worldwide each year.ADNFCR-1506-ID-18689148-ADNFCR


Health Headlines

In a lab animal model, booming gut flora spawned by the Western diet is linked to obesity.
International study reaffirms importance of resolving the income gap between the richest and poorest people in developed countries.
Switzerland-based research team assesses the metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress hormones.
UCLA researchers find disability rates in Americans entering their 60s are on the rise, potentially fueled by the overweight/obesity epidemic.
Genetic clues to longevity discovered among a homogenous ethnic population.
Rush Alzheimer's Disease Center (USA) researchers find that a loss of muscle strength raises risk of Alzheimer’s Disease and mild cognitive impairment.
Stroke risk may rise in those with common infectious pathogens such as Chlamydia pneumoniae, Helicobacter pylori, and herpes simplex viruses.
First study in humans links bisphenol A (BPA) exposure to male sexual function problems.
Simple steps in the community can promote walking among residents.
Study finds that people who are dissatisfied with their workplace bosses not only take more sick leave, but are at increased risk of suffering a heart attack.
Looking for an Anti-aging Doctor?

upcoming Events

U.S. Events
congresses
Las Vegas
fellowships
fellowships
symposium
workshops
  • Advanced Hormone Symposium
    Chicago, IL | Oct. 8-10, 2010

VIDEO: Brain Age Workshop
Dr. Eric Braverman, Director of The Place for Achieving Total Health (PATH Medical), Chairs the Brain Age Workshop taking place Dec. 9, 2009. Held in conjunction with the Winter Session of the 17th Annual World Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies. The Brain Age Workshop features presentations on Brain Mind Assessment via Neuropsychological Analysis, Movement Deficiency Syndrome, Hormones and the Brain, Nootropic Drug Mechanisms, and Traumatic Brain Injury. View this video to learn about Dr. Braverman’s brain-based model of aging and age modulation.

International Events
See all events »